Pancreatic cancer is staged from I to IV based on three factors: the size of the tumor, whether it has reached nearby lymph nodes, and whether it has spread to distant organs. There is also a Stage 0, which describes precancerous cells confined to the surface layer of the pancreatic duct. Most people searching for the “4 stages” want to understand Stages I through IV, which represent progressively more advanced disease.
How Pancreatic Cancer Is Staged
Staging relies on imaging, primarily contrast-enhanced CT scans for the initial diagnosis and MRI when doctors need a closer look at the liver. These scans help determine how large the tumor is, whether it has grown into nearby blood vessels, and whether cancer has appeared in other organs. Imaging is less reliable for detecting cancer in lymph nodes, so the full picture often becomes clearer after surgery, when tissue can be examined directly.
The staging system currently in use is the AJCC 8th Edition, which remains the standard for pancreatic adenocarcinoma (the most common type) through at least 2026.
Stage I: Cancer Confined to the Pancreas
In Stage I, the tumor is still entirely within the pancreas and has not reached any lymph nodes or distant organs. It is split into two substages based on size:
- Stage IA: The tumor is 2 cm (about ¾ inch) or smaller.
- Stage IB: The tumor is larger than 2 cm but no more than 4 cm (roughly 1.5 inches).
Stage I pancreatic cancer is the most treatable because the tumor can typically be removed with surgery. The five-year relative survival rate for localized pancreatic cancer is 43.6%, according to SEER data from 2016 to 2022. That number is dramatically higher than later stages, which is why early detection matters so much. Unfortunately, pancreatic cancer rarely causes obvious symptoms at this point, so only a small percentage of cases are caught this early.
Stage II: Larger Tumors or Limited Lymph Node Spread
Stage II covers two distinct scenarios:
- Stage IIA: The tumor has grown larger than 4 cm but is still confined to the pancreas, with no lymph node involvement.
- Stage IIB: The tumor is any size (still within the pancreas) but cancer has spread to 1 to 3 nearby lymph nodes.
The key distinction from Stage I is either increased size or the first signs that cancer cells have traveled beyond the tumor itself. Surgery is still possible for many Stage II patients, often followed by chemotherapy to target any remaining cancer cells. The presence of cancer in lymph nodes is a significant marker because it means cells have entered the body’s drainage system, raising the risk of further spread. The five-year relative survival for regional-stage disease (which includes Stage II and Stage III) drops to about 17%.
Stage III: Locally Advanced Disease
Stage III pancreatic cancer means the disease has progressed in one of two ways, but has not yet spread to distant organs:
- The tumor (of any size, still within the pancreas) has spread to 4 or more nearby lymph nodes.
- The tumor has grown beyond the pancreas into major blood vessels nearby, including the arteries that supply the gut and liver. When this happens, the number of affected lymph nodes no longer matters for staging purposes.
Growth into major blood vessels is what doctors call “locally advanced” disease, and it often makes surgical removal difficult or impossible. When the tumor wraps around or invades these critical arteries, the risks of surgery may outweigh the benefits. Treatment at this stage typically focuses on chemotherapy, sometimes combined with radiation, with the goal of shrinking the tumor. In some cases, if treatment works well enough, a tumor that was initially considered inoperable can become a candidate for surgery.
For patients where surgery is not an option, treatment shifts toward controlling the cancer’s growth and managing symptoms like pain, digestive problems, and weight loss.
Stage IV: Distant Spread
Stage IV means cancer has spread to distant organs. The tumor can be any size and may or may not involve lymph nodes. What defines this stage is the presence of metastases, most commonly in the liver, lungs, or the peritoneum (the thin lining of the abdominal cavity). Bone metastases are also possible, though less frequent.
About half of all pancreatic cancers are already Stage IV at diagnosis. The five-year relative survival rate for distant-stage disease is 3.4%. Treatment at this stage is palliative, meaning its primary aim is to slow the cancer, relieve symptoms, and improve quality of life rather than cure the disease. Chemotherapy is the main treatment, sometimes combined with targeted therapy depending on the specific genetic features of the cancer.
Palliative care can address many of the complications that affect daily life, including pain management, bile duct blockages that cause jaundice, and nutritional support for the weight loss and appetite changes that are common with advanced pancreatic cancer.
Why Stage Matters for Treatment Decisions
The single biggest factor in pancreatic cancer treatment is whether the tumor can be surgically removed. Surgery is the only approach that offers a chance of long-term survival, and it is generally only possible in Stages I and II, and occasionally in Stage III after chemotherapy shrinks the tumor. Once cancer has spread to distant organs, surgery on the primary tumor no longer changes the outcome.
Doctors also classify tumors using a parallel system based on surgical feasibility: resectable (can be removed), borderline resectable (might be removable after treatment), and unresectable (cannot be safely removed). This classification does not replace staging but works alongside it to guide treatment planning. A Stage III tumor that responds well to chemotherapy might move from unresectable to borderline resectable, opening the door to surgery that was not initially an option.
Because pancreatic cancer is so often diagnosed at an advanced stage, and because early-stage survival rates are dramatically better, there is significant focus on identifying people at higher risk through screening programs. If you have a strong family history of pancreatic cancer or carry certain genetic mutations linked to it, screening with specialized imaging may catch the disease at a stage where treatment can make the greatest difference.